the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� .
"we were quite surprised to find there were no significant differences," says study author .
all programs
-
.
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.